Compare INFU & SWKH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | INFU | SWKH |
|---|---|---|
| Founded | 2005 | 1996 |
| Country | United States | United States |
| Employees | N/A | 9 |
| Industry | Medical/Dental Instruments | Diversified Financial Services |
| Sector | Health Care | Finance |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 182.4M | 198.4M |
| IPO Year | 2005 | N/A |
| Metric | INFU | SWKH |
|---|---|---|
| Price | $9.55 | $16.43 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 2 | 1 |
| Target Price | $15.00 | ★ $18.00 |
| AVG Volume (30 Days) | ★ 139.5K | 7.5K |
| Earning Date | 01-01-0001 | 01-01-0001 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 181.82 | N/A |
| EPS | ★ 0.31 | N/A |
| Revenue | ★ $143,436,000.00 | N/A |
| Revenue This Year | $5.29 | $52.93 |
| Revenue Next Year | $8.95 | N/A |
| P/E Ratio | $29.55 | ★ $9.18 |
| Revenue Growth | ★ 6.36 | N/A |
| 52 Week Low | $4.61 | $13.00 |
| 52 Week High | $11.04 | $18.66 |
| Indicator | INFU | SWKH |
|---|---|---|
| Relative Strength Index (RSI) | 66.19 | 38.81 |
| Support Level | $8.57 | $16.15 |
| Resistance Level | $9.80 | $17.71 |
| Average True Range (ATR) | 0.49 | 0.24 |
| MACD | 0.22 | -0.04 |
| Stochastic Oscillator | 100.00 | 29.45 |
InfuSystems Holdings Inc is a health care service provider, facilitating outpatient care for durable medical equipment manufacturers and health care providers. INFU services are provided under a two-reportable segment. The first is Patient Services, providing the last-mile solution for clinic-to-home healthcare where the continuing treatment involves complex durable medical equipment and services. The Patient segment is comprised of Oncology, Pain Management and Wound Therapy businesses. The second, Device Solutions, supports the Patient Services platform and leverages service orientation to win incremental business from its direct payer clients. The Device segment is comprised of direct payer rentals, pump and consumable sales, and biomedical services and repair. Majority from Patient.
SWK Holdings Corp is a healthcare capital provider. The company offers financing solutions to various life science companies, institutions, and inventors. It involves monetizing cash flow streams derived from commercial-stage products and related intellectual property through royalty purchases and financings, as well as through the creation of synthetic revenue interests in commercialized products. Through its wholly-owned subsidiary, it also provides non-discretionary investment advisory services to institutional clients. The company's operating segments are Finance Receivables and Pharmaceutical Development Services. It generates maximum revenue from the Finance Receivables segment.